"At the University of New Mexico Comprehensive Cancer Center, our cancer care includes chemotherapy, surgery, radiation therapy, immunotherapy and clinical trials. The UNM Comprehensive Cancer Center is the only one in New Mexico designated by the National Cancer Institute. Learn about our 12 teams who specialize in all types of cancers. Our supportive services assist with cancer genetics counseling, nutritional counseling and more."

During the past decade, UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045)" #1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045)" are "Urinary Bladder Cancer, Muscle-invasive" (2 trials). Many other conditions were trialed in "UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045)" in a lesser frequency.

Most popular intervention types in "UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045)" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (2 trials), "Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])" (2 trials), "Cisplatin" (1 trials), "Enfortumab Vedotin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNM Comprehensive Cancer Center-Clinical Research Office ( Site 0045), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".